CompaniesInvestorsPeople
Home
Loading

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

aVenture is in Beta: research coverage is expanding as we build, so please independently verify key details before making investment decisions.

Get in Touch

  • Contact

  • Request a Demo

  • Request Data Updates

  • Add a Company

Research

  • Companies

  • Investors

  • People

aVenture

  • Download App

  • Pricing

Download the aVenture Research beta for iOS and iPadOSDownload aVenture Research on the Mac App Store

Resources

  • Documentation

  • Use Cases

  • CLI

  • MCP

  • Feature Requests

  • Sitemap

Member

Backed by

Ask AI about aVenture

© aVenture Investment Company, 2026. All rights reserved.

San Francisco, CA, USA

Privacy · Terms of Service

aVenture Investment Company ("aVenture") is an independent research platform providing detailed analysis and data on startups, venture capital investments, and key industry individuals. It is not a registered investment adviser, broker-dealer, or investment advisor and does not provide investment advice or recommendations. The data provided by aVenture does not constitute recommendations or advice, whether by methodology, analysis, AI-generated content, or a statement written by a staff member of aVenture.

aVenture is not affiliated with any of the people, companies, organizations, government agencies, regulatory bodies, or investment funds we provide coverage for on this site unless explicitly stated otherwise. Users assume full responsibility for decisions made based on information obtained from this platform. Links to external websites do not imply endorsement or affiliation with aVenture. Any links that provide the ability to invest in a primary or secondary transaction in a company are for convenience only and do not constitute solicitations or offers to buy or sell an investment. Investors should exercise heightened precaution and due diligence when investing in private companies, especially those not independently audited.

While we strive to provide valuable insights with objectivity and professional diligence, we cannot guarantee the accuracy of the information provided on our platform. Before making any investment decisions, you should verify the accuracy of all pertinent details for your decision. To the fullest extent permitted by law, aVenture shall not be liable for any direct, indirect, incidental, consequential, or financial damages arising from use of this site, whether by consumers of its contents directly or by persons or organizations covered by our research, even if we are advised of the possibility. Our best-efforts processes and correction request forms do not create a warranty or duty of care.

Profiles on this platform may include content generated in part by large language models (LLMs, artificial intelligence) that aggregate publicly available sources (e.g., SEC EDGAR, public filings, press releases). Source attribution is provided where known; always verify statements and claims here against original sources before relying on any data. Content on our site may contain inaccuracies, omissions, or what are commonly called 'hallucinations' if generated in part or in full by AI / LLMs. The risk can also exist even when content is written by a human, as internal and third-party sources may also have inaccuracies for the same or different reasons. While we randomly audit a proportion of content, this is not exhaustive.

We recommend that an independent auditor be hired to verify the accuracy of the information before relying on it for any sensitive decisions. By accessing this platform, you agree not to rely solely on any information generated by AI, aggregated, or sourced or written otherwise on this site, for investment, financial, or other decisions. aVenture assumes no responsibility for inaccuracies, omissions, or hallucinations. You must independently verify all data from primary sources. Use of this platform constitutes your waiver of claims for reliance-based damages, including negligent misrepresentation. To report an error, request a correction, or dispute information about a company or individual, contact us via our request data updates form.

Loading
Home›
Companies›
Fluxergy
Fluxergy logo

Fluxergy

Fluxergy: Innovating handheld medical diagnostics with multi-modal detection for diverse lab tests.

Irvine, CA, US🇺🇸
Founded
2011
Overview
Compare
Fundraising
Employees
Library

Fluxergy, a medical diagnostics company, was founded with the mission to revolutionize point-of-care testing by bringing the variety of tests found in central labs to handheld devices. Their innovative platform integrates multi-modal detection technologies, enabling rapid and accurate molecular, immunochemistry, chemistry, PCR, and cytometry assays. Fluxergy aims to make laboratory-quality diagnostics accessible and affordable, catering to markets including clinical diagnostics, assay development, and equine health.

Notable figures associated with Fluxergy include leading experts in biomedical engineering and diagnostics. The company has attracted significant investment from prominent venture capital firms. Key achievements include the development of the first open platform for multimodal point-of-care assay development and testing, which has been recognized for its potential to transform healthcare delivery. Fluxergy's impact is evident in its ability to provide fast, reliable diagnostic results anywhere, significantly improving patient care and operational efficiency in various medical settings.

Fluxergy - Similar Companies

BioCeryx logo

BioCeryx

General Fluidics logo

General Fluidics

Prompt Diagnostics logo

Prompt Diagnostics

prompt-dx.com

Proxim Diagnostics logo

Proxim Diagnostics

Fluxergy - Quick Facts

Who are Fluxergy's competitors?

Companies similar to Fluxergy include BioCeryx, General Fluidics, Prompt Diagnostics and Proxim Diagnostics.

When was Fluxergy founded?

Fluxergy was founded in 2011.

Where is Fluxergy's headquarters located?

Fluxergy's headquarters is located in Irvine, CA, US.

When was Fluxergy's last funding round?

Fluxergy's most recent funding round was for $30M (USD) in May 2020.

How much disclosed funding has Fluxergy raised?

As of May 13, 2020, Fluxergy has disclosed funding of $50M (USD). Undisclosed round amounts are excluded.

Fluxergy - Classification

Industry
  • Hardware
Ownership
  • Private
  • Venture-backed
Technology
  • AI

How many employees does Fluxergy have?

Fluxergy has 88 employees as of Feb 4, 2024.

Analytics
Geographic Exposure
  • Global
Model
  • Platform
Revenue
  • Recurring
  • Transactional
Customer
  • Enterprise
Main Product
  • Labtesting
  • Medicaldiagnostics
Tags
  • Biotech
  • Healthcare
  • Healthtech
NAICS
  • 540000Professional, Scientific, and Technical Services
  • 541500Computer Systems Design and Related Services
  • 541000Professional, Scientific, and Technical Services
  • 541510Computer Systems Design and Related Services
  • 541511Custom Computer Programming Services
SIC
  • 7300Business Services
  • 7370Computer Programming, Data Processing, And Other Computer Related
  • 7371Computer Programming Services
Show 9 more industry codes
NAICS
  • 513200Software Publishers
  • 510000Information
  • 620000Health Care and Social Assistance
  • 513000Publishing Industries
  • 513210Software Publishers
SIC
  • 8000Health Services
  • 8040Offices And Clinics Of Other Health Practitioners

proximdx.com

Instadiagnostics logo

Instadiagnostics

Alveo Technologies logo

Alveo Technologies

Genalyte logo

Genalyte

genalyte.com

Chemeleon logo

Chemeleon

chemeleon.com

OmniVis logo

OmniVis

omnivistech.com

First Light Diagnostics logo

First Light Diagnostics

firstlightbio.com

Fluorofinder logo

Fluorofinder

fluorofinder.com

FYR Diagnostics logo

FYR Diagnostics

fyrdiagnostics.com

Exactus logo

Exactus

exactusinc.com

SenGenix logo

SenGenix

sengenix.com

HX Diagnostics logo

HX Diagnostics

7372
Prepackaged Software
  • 8049Offices And Clinics Of Health Practitioners, Not Elsewhere Classified